BIO International Convention 2023

Morrison Foerster partner Stacy Amin will moderate a panel on "In Vitro Diagnostics Regulation in the US and Beyond: Trends and Strategies to Navigate Change" at the BIO International Convention in Boston, MA.

In vitro diagnostics have seen incredible innovation during the COVID-19 pandemic, and advances in real world evidence, precision medicine, genetic sequencing, and AI/ML driven software have made this one of the fastest developing industries. However, the regulatory landscape for in vitro diagnostics is in a state of change and uncertainty. Europe's new IVDR law has brought new regulatory challenges for test developers. Meanwhile, FDA has hinted at its intention to regulate laboratory developed tests, and has taken an enforcement posture toward direct-to-consumer, pharmacogenetic, and certain genetic screening tests. This panel will discuss the most important trends in the industry, the VALID Act and Congressional efforts to bring about regulatory clarity, the latest actions from FDA, and how industry should navigate these shifting sands in the U.S. and internationally.

Panelists:

• Elizabeth Hillebrenner, Associate Director for Scientific and Regulatory Programs, FDA Center for Devices and Radiological Health

• Shilpa Prem, Corporate Counsel, Amazon Lab126
• Lauren Silvis, Senior Vice President of External Affairs, Tempus

Register or learn more.